Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors

Yuji Takeda, Koji Tsuta, Yasuo Shibuki, Tatsuhiro Hoshino, Naobumi Tochigi, Akiko Miyagi Maeshima, Hisao Asamura, Yuko Sasajima, Tsuyoshi Ito, Yoshihiro Matsuno

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Context. - The lung is the most common site of metastasis during the natural history of malignant tumors. Breast carcinoma has a propensity for distant metastasis, and the lung and pleura are among the most common metastatic sites. Although it is often difficult to make a clear-cut differential diagnosis between the two, distinguishing primary lung carcinoma from breast carcinoma metastatic to the lung is important because the treatment modalities are different. Objective. - To elucidate the utility of mammaglobin and gross cystic disease fluid protein 15 (GCDFP-15), which are known to be breast-specific antigens, in distinguishing various primary lung and pleural tumors from breast carcinoma metastasizing to the lung. Design. - A total of 20 cases of breast carcinoma metastatic to the lung and 263 tumors of nonbreast origin located in the lung and pleura were analyzed. Results. - Of the 20 cases of breast carcinoma metastatic to the lung, 10 (50.0%) were immunoreactive for mammaglobin and 9 (45.0%) for GCDFP-15, the frequency of positivity being slightly higher for the former than for the latter. The area immunopositive for mammaglobin showed more diffuse staining than the area immunopositive for GCDFP-15. Furthermore, the specificity of mammaglobin for breast carcinoma metastatic to the lung was superior (98.9%) to that of GCDFP-15 (91.8%). Conclusion. - The sensitivity of mammaglobin is equal or superior to that of GCDFP-15 for investigation of breast carcinoma. Immunopositivity for mammaglobin is more diffuse than that for GCDFP-15. In terms of practical diagnosis, mammaglobin immunohistochemistry can serve as a differential marker of breast carcinoma and should be added to the immunohistochemical panel.

Original languageEnglish
Pages (from-to)239-243
Number of pages5
JournalArchives of Pathology and Laboratory Medicine
Volume132
Issue number2
Publication statusPublished - 2008 Feb
Externally publishedYes

Fingerprint

Breast Neoplasms
Lung
Neoplasms
Proteins
Pleura
Neoplasm Metastasis
Breast
Differential Diagnosis
Immunohistochemistry
Staining and Labeling
Carcinoma
Antigens

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors. / Takeda, Yuji; Tsuta, Koji; Shibuki, Yasuo; Hoshino, Tatsuhiro; Tochigi, Naobumi; Maeshima, Akiko Miyagi; Asamura, Hisao; Sasajima, Yuko; Ito, Tsuyoshi; Matsuno, Yoshihiro.

In: Archives of Pathology and Laboratory Medicine, Vol. 132, No. 2, 02.2008, p. 239-243.

Research output: Contribution to journalArticle

Takeda, Y, Tsuta, K, Shibuki, Y, Hoshino, T, Tochigi, N, Maeshima, AM, Asamura, H, Sasajima, Y, Ito, T & Matsuno, Y 2008, 'Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors', Archives of Pathology and Laboratory Medicine, vol. 132, no. 2, pp. 239-243.
Takeda, Yuji ; Tsuta, Koji ; Shibuki, Yasuo ; Hoshino, Tatsuhiro ; Tochigi, Naobumi ; Maeshima, Akiko Miyagi ; Asamura, Hisao ; Sasajima, Yuko ; Ito, Tsuyoshi ; Matsuno, Yoshihiro. / Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors. In: Archives of Pathology and Laboratory Medicine. 2008 ; Vol. 132, No. 2. pp. 239-243.
@article{11549dc8c50a479dabad03d651f5c469,
title = "Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors",
abstract = "Context. - The lung is the most common site of metastasis during the natural history of malignant tumors. Breast carcinoma has a propensity for distant metastasis, and the lung and pleura are among the most common metastatic sites. Although it is often difficult to make a clear-cut differential diagnosis between the two, distinguishing primary lung carcinoma from breast carcinoma metastatic to the lung is important because the treatment modalities are different. Objective. - To elucidate the utility of mammaglobin and gross cystic disease fluid protein 15 (GCDFP-15), which are known to be breast-specific antigens, in distinguishing various primary lung and pleural tumors from breast carcinoma metastasizing to the lung. Design. - A total of 20 cases of breast carcinoma metastatic to the lung and 263 tumors of nonbreast origin located in the lung and pleura were analyzed. Results. - Of the 20 cases of breast carcinoma metastatic to the lung, 10 (50.0{\%}) were immunoreactive for mammaglobin and 9 (45.0{\%}) for GCDFP-15, the frequency of positivity being slightly higher for the former than for the latter. The area immunopositive for mammaglobin showed more diffuse staining than the area immunopositive for GCDFP-15. Furthermore, the specificity of mammaglobin for breast carcinoma metastatic to the lung was superior (98.9{\%}) to that of GCDFP-15 (91.8{\%}). Conclusion. - The sensitivity of mammaglobin is equal or superior to that of GCDFP-15 for investigation of breast carcinoma. Immunopositivity for mammaglobin is more diffuse than that for GCDFP-15. In terms of practical diagnosis, mammaglobin immunohistochemistry can serve as a differential marker of breast carcinoma and should be added to the immunohistochemical panel.",
author = "Yuji Takeda and Koji Tsuta and Yasuo Shibuki and Tatsuhiro Hoshino and Naobumi Tochigi and Maeshima, {Akiko Miyagi} and Hisao Asamura and Yuko Sasajima and Tsuyoshi Ito and Yoshihiro Matsuno",
year = "2008",
month = "2",
language = "English",
volume = "132",
pages = "239--243",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "2",

}

TY - JOUR

T1 - Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors

AU - Takeda, Yuji

AU - Tsuta, Koji

AU - Shibuki, Yasuo

AU - Hoshino, Tatsuhiro

AU - Tochigi, Naobumi

AU - Maeshima, Akiko Miyagi

AU - Asamura, Hisao

AU - Sasajima, Yuko

AU - Ito, Tsuyoshi

AU - Matsuno, Yoshihiro

PY - 2008/2

Y1 - 2008/2

N2 - Context. - The lung is the most common site of metastasis during the natural history of malignant tumors. Breast carcinoma has a propensity for distant metastasis, and the lung and pleura are among the most common metastatic sites. Although it is often difficult to make a clear-cut differential diagnosis between the two, distinguishing primary lung carcinoma from breast carcinoma metastatic to the lung is important because the treatment modalities are different. Objective. - To elucidate the utility of mammaglobin and gross cystic disease fluid protein 15 (GCDFP-15), which are known to be breast-specific antigens, in distinguishing various primary lung and pleural tumors from breast carcinoma metastasizing to the lung. Design. - A total of 20 cases of breast carcinoma metastatic to the lung and 263 tumors of nonbreast origin located in the lung and pleura were analyzed. Results. - Of the 20 cases of breast carcinoma metastatic to the lung, 10 (50.0%) were immunoreactive for mammaglobin and 9 (45.0%) for GCDFP-15, the frequency of positivity being slightly higher for the former than for the latter. The area immunopositive for mammaglobin showed more diffuse staining than the area immunopositive for GCDFP-15. Furthermore, the specificity of mammaglobin for breast carcinoma metastatic to the lung was superior (98.9%) to that of GCDFP-15 (91.8%). Conclusion. - The sensitivity of mammaglobin is equal or superior to that of GCDFP-15 for investigation of breast carcinoma. Immunopositivity for mammaglobin is more diffuse than that for GCDFP-15. In terms of practical diagnosis, mammaglobin immunohistochemistry can serve as a differential marker of breast carcinoma and should be added to the immunohistochemical panel.

AB - Context. - The lung is the most common site of metastasis during the natural history of malignant tumors. Breast carcinoma has a propensity for distant metastasis, and the lung and pleura are among the most common metastatic sites. Although it is often difficult to make a clear-cut differential diagnosis between the two, distinguishing primary lung carcinoma from breast carcinoma metastatic to the lung is important because the treatment modalities are different. Objective. - To elucidate the utility of mammaglobin and gross cystic disease fluid protein 15 (GCDFP-15), which are known to be breast-specific antigens, in distinguishing various primary lung and pleural tumors from breast carcinoma metastasizing to the lung. Design. - A total of 20 cases of breast carcinoma metastatic to the lung and 263 tumors of nonbreast origin located in the lung and pleura were analyzed. Results. - Of the 20 cases of breast carcinoma metastatic to the lung, 10 (50.0%) were immunoreactive for mammaglobin and 9 (45.0%) for GCDFP-15, the frequency of positivity being slightly higher for the former than for the latter. The area immunopositive for mammaglobin showed more diffuse staining than the area immunopositive for GCDFP-15. Furthermore, the specificity of mammaglobin for breast carcinoma metastatic to the lung was superior (98.9%) to that of GCDFP-15 (91.8%). Conclusion. - The sensitivity of mammaglobin is equal or superior to that of GCDFP-15 for investigation of breast carcinoma. Immunopositivity for mammaglobin is more diffuse than that for GCDFP-15. In terms of practical diagnosis, mammaglobin immunohistochemistry can serve as a differential marker of breast carcinoma and should be added to the immunohistochemical panel.

UR - http://www.scopus.com/inward/record.url?scp=38949143302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38949143302&partnerID=8YFLogxK

M3 - Article

C2 - 18251583

AN - SCOPUS:38949143302

VL - 132

SP - 239

EP - 243

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 2

ER -